Home

Cipla Ltd PE Ratio

Image

Cipla Ltd

NSE: CIPLA

PE

23.5

Last updated on: Feb 12, 2025

Key Highlights

  • The P/E Ratio of Cipla Ltd is 23.5 as of 12 Feb 15:30 PM .
  • The P/E Ratio of Cipla Ltd changed from 22 on March 2020 to 29.3 on March 2024 . This represents a CAGR of 5.90% over 5 years.
  • The Latest Trading Price of Cipla Ltd is ₹ 1449 as of 12 Feb 15:30 .
  • The PE Ratio of Pharmaceuticals Industry has changed from 21.0 to 40.0 in 5 years. This represents a CAGR of 13.75%.
  • The PE Ratio of Automobile industry is 20.3. The PE Ratio of Finance industry is 17.8. The PE Ratio of IT - Software industry is 30.3. The PE Ratio of Pharmaceuticals industry is 40.0. The PE Ratio of Retail industry is 157.6. The PE Ratio of Textiles industry is 36.9 in 2024.

Historical P/E Ratio of Cipla Ltd

No data available

Company Fundamentals for Cipla Ltd

Image

Cipla Ltd

NSE: CIPLA

Share Price

₹ 1449.8

-2.90 (-0.20%)

stock direction

Last updated on: Feb 12, 2025

Market Price of Cipla Ltd

1M

1Y

3Y

5Y

Monitoring Cipla Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
12 Feb 20251449.8
11 Feb 20251452.7
10 Feb 20251458.35
07 Feb 20251472.3
06 Feb 20251471.65
05 Feb 20251436.6
04 Feb 20251448.7
03 Feb 20251420.9
01 Feb 20251437.85
31 Jan 20251479.35

SWOT Analysis Of Cipla Ltd

Strength

3

che

Weakness

1

che

Opportunity

0

che

Threats

1

che

BlinkX Score for Cipla Ltd

Asset Value vs Market Value of Cipla Ltd

Market Value

0

Asset Value

0

* All values are in ₹ crores

Competitive Comparison of P/E Ratio

Company
leftMarket Capright
Cipla Ltd117087
Sun Pharmaceuticals Industries Ltd406363
Divis Laboratories Ltd158396
Torrent Pharmaceuticals Ltd103663
Dr Reddys Laboratories Ltd101458
Mankind Pharma Ltd99897

PE Ratio of Cipla Ltd Explained

117087

Market cap

4989

Earnings

23.5X

PE Ratio

The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share.


P/E Ratio Formula


P/E ratio = (CMP of share/ Earning per share)


Types of Price to Earning Ratio


1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance.
2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.

PE Ratio of Pharmaceuticals Industry over time

PE Ratio of Top Sectors

Historical Market Cap of Cipla Ltd

No data available

* All values are in crore

Historical Revenue, EBITDA and Net Profit of Cipla Ltd

Revenue

EBITDA

Net Profit

No data available

* All values are in crore

Historical Dividend Payout of Cipla Ltd

No data available

* All values are in %

About Cipla Ltd

  • Cipla Ltd is one of the leading pharmaceutical companies in India.
  • The Company is in the business of manufacturing, developing, and marketing wide range of branded and generic formulations and Active Pharmaceutical Ingredients (APIs).
  • Cipla's product portfolio spans complex generics as well as drugs in the respiratory, anti-retroviral, urology, cardiology, anti-infective, CNS, and various other key therapeutic segments.
  • With a rich portfolio, it is deepening presence in the home markets of India, as well as South Africa, North America, and other key regulated and emerging markets.
  • Its 47 manufacturing sites around the world produce more than 50 dosage forms and over 1,500 products across wide range of therapeutic categories. Cipla Ltd was incorporated in the year 1935 with the name Chemical, Industrial & Pharmaceutical Laboratories Ltd.

Cipla Ltd News Hub

Cipla Ltd up for five straight sessions

Cipla Ltd is up for a fifth straight session in a row. The stock is quoting at Rs 1586.85, up 0.77%

Read more

12 Aug 24

Cipla Ltd gains for third straight session

Cipla Ltd is up for a third straight session today. The stock is quoting at Rs 1574.65, up 1.36% on

Read more

08 Aug 24

Cipla allots 6,815 equity shares under ESOS

Cipla has allotted 6,815 equity shares under Employee Stock Option Scheme on 02 August 2024. Consequ

Read more

02 Aug 24

Cipla announces board meeting date

Cipla will hold a meeting of the Board of Directors of the Company on 3 September 2024. Powered by C

Read more

04 Sept 24

Product Composition by Percentage (Revenue)

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for PE of Cipla Ltd

What is the current PE Ratio of Cipla Ltd?

The Current PE Ratio of Cipla Ltd is 23.47 as on 12 Feb 2025.

What is the average PE Ratio of the Pharmaceuticals industry?

The average industry PE Ratio of Pharmaceuticals is 40.0 as on 12 Feb 2025.

What was the PE Ratio of Cipla Ltd last year?

The PE Ratio of Cipla Ltd was 25.95 last year, now the PE ratio is 23.47, showing a year-on-year growth of -9.6%.

What does the PE Ratio of Cipla Ltd indicate about its stock?

The PE Ratio of Cipla Ltd is 23.47. This ratio indicates that investors are willing to pay 23.47 times the earnings per share for each share of Cipla Ltd.

What is the PE Ratio Growth of Cipla Ltd in comparison to its Earnings per Share (EPS) growth rate?

The PE Ratio of Cipla Ltd grew by -9.6% whereas, the EPS ratio grew by 20.6.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions